osteopenia research hub

Senolytics to Improve Osteoporosis therapy: A randomised controlled clinical trial The SENIOR Trial

This study, called THE SENIOR Trial, is looking into a new treatment for weak bones (osteopenia and osteoporosis). It investigates if a medicine called DASATINIB can improve bone health by slowing down bone breakdown. We're measuring changes in a blood marker of bone breakdown after 21 weeks.